1. Home
  2. DRMA vs DGLY Comparison

DRMA vs DGLY Comparison

Compare DRMA & DGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRMA
  • DGLY
  • Stock Information
  • Founded
  • DRMA 2014
  • DGLY 2004
  • Country
  • DRMA United States
  • DGLY United States
  • Employees
  • DRMA N/A
  • DGLY 31
  • Industry
  • DRMA Biotechnology: Pharmaceutical Preparations
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • DRMA Health Care
  • DGLY Technology
  • Exchange
  • DRMA Nasdaq
  • DGLY Nasdaq
  • Market Cap
  • DRMA 4.5M
  • DGLY 4.2M
  • IPO Year
  • DRMA 2021
  • DGLY N/A
  • Fundamental
  • Price
  • DRMA $0.75
  • DGLY $2.47
  • Analyst Decision
  • DRMA Strong Buy
  • DGLY
  • Analyst Count
  • DRMA 1
  • DGLY 0
  • Target Price
  • DRMA $3.00
  • DGLY N/A
  • AVG Volume (30 Days)
  • DRMA 70.9K
  • DGLY 1.3M
  • Earning Date
  • DRMA 05-14-2025
  • DGLY 05-21-2025
  • Dividend Yield
  • DRMA N/A
  • DGLY N/A
  • EPS Growth
  • DRMA N/A
  • DGLY N/A
  • EPS
  • DRMA N/A
  • DGLY N/A
  • Revenue
  • DRMA N/A
  • DGLY $18,596,715.00
  • Revenue This Year
  • DRMA N/A
  • DGLY N/A
  • Revenue Next Year
  • DRMA N/A
  • DGLY N/A
  • P/E Ratio
  • DRMA N/A
  • DGLY N/A
  • Revenue Growth
  • DRMA N/A
  • DGLY N/A
  • 52 Week Low
  • DRMA $0.66
  • DGLY $1.93
  • 52 Week High
  • DRMA $5.00
  • DGLY $320.00
  • Technical
  • Relative Strength Index (RSI)
  • DRMA 44.67
  • DGLY 23.18
  • Support Level
  • DRMA $0.66
  • DGLY $2.23
  • Resistance Level
  • DRMA $0.75
  • DGLY $2.73
  • Average True Range (ATR)
  • DRMA 0.05
  • DGLY 0.59
  • MACD
  • DRMA 0.00
  • DGLY 3.20
  • Stochastic Oscillator
  • DRMA 44.50
  • DGLY 16.17

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc. is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

Share on Social Networks: